Synopsis of recent research by authors named "Reid Rubsamen"
- Reid Rubsamen's recent research focuses on the design and evaluation of novel vaccines targeting various viral and cancer-associated antigens, including a Marburg virus vaccine and survivin peptide vaccines for breast cancer.
- His studies emphasize the importance of bioinformatics, immunological profiling, and integrative HLA typing to enhance understanding of immune responses and to design effective immunotherapies against diseases like COVID-19 and breast cancer.
- Rubsamen has compiled significant findings surrounding the immune response modifications due to HLA variations, potential vaccine efficacy against viral mutations, and the role of survivin as a promising target in immuno-oncology.